A subscription to JoVE is required to view this content. Sign in or start your free trial.
New coronary artery stent designs and materials must be tested before clinical use in relevant preclinical models. Here we describe an atherosclerotic rabbit aorta model and a pig coronary artery model for stent research with in vivo and histological analyses.
Coronary artery disease is a major contributor to morbidity and mortality worldwide. While lifestyle changes and medication are the cornerstones of treatment, coronary artery balloon angioplasty and stenting are routinely performed on patients with acute coronary syndromes and chronic coronary artery disease who remain symptomatic with optical medical treatment. Several generations of coronary stents have been developed over recent decades. Balloon angioplasty and stenting are supported by the use of pharmaceutical agents applied onto balloons and the stent surface, either to advance the healing properties of the artery post-intervention or to prevent the formation of restenosis. New devices need to be rigorously tested for safety and efficacy before acceptance into clinical practice; thus, there is a continuing need for reliable and reproducible preclinical methods of stent evaluation. We describe here a pig coronary artery model as well as an atherosclerotic rabbit model for coronary artery stent research and describe basic steps in intravascular imaging and stent histology.
Atherosclerotic coronary artery disease causes a significant burden on the healthcare systems of countries across the globe1. Coronary artery balloon angioplasty and stenting are routinely performed on patients suffering from acute coronary syndromes as well as symptomatic patients with stable coronary artery disease2. Balloon angioplasty was a revolutionary invention to revascularize narrowed or even occluded coronary arteries. Coronary artery stents further improved the results of percutaneous coronary interventions (PCIs) by preventing acute recoil of the artery following balloon angioplasty
All animal experiments were approved by the Animal Experiment Board in Finland. Adult 3.0-4.0 kg New Zealand White (NZW) rabbits were used for the atherosclerotic rabbit model. For the pig coronary study, the animals weighed 30-40 kg at the start of the experiment. The protocol for the rabbit atherosclerotic model and the pig coronary artery model is described separately, followed by the description of how histology can be performed for non-degradable coronary stents, regardless of the in vivo model used.
Successful stent expansion must be confirmed with angiography and ideally with intravascular imaging (Figure 3A,B). The pig coronary artery model allows for multiple imaging sessions, and OCT can be used to create follow-up data with frequent imaging. ISR and stent expansion, and possible strut fractures can easily be evaluated from angiographic and OCT imaging. Intravascular imaging also produces data along the length of the whole stent, unlike histology, which usually can .......
While the current generation of drug-eluting coronary stents have proven their merits, new devices are being developed to better suit the needs of patients and healthcare professionals. The first round of fully biodegradable coronary scaffolds met several challenges, which further underlines the importance of testing new devices in biologically relevant models9. The models presented here provide two options for conducting stent research. The coronary model should be applied and is generally requir.......
The authors acknowledge the expert assistance of Heikki Karhunen, Minna Törrönen, and Riikka Venäläinen from the National Laboratory Animal Center at the University of Eastern Finland. This study was supported by the Finnish Academy Flagship grant.
....Name | Company | Catalog Number | Comments |
Angiographic puncture needle | Cordis | 12-004943 | |
Aspirin Cardio 100 mg | Bayer | ||
Cholesterol | Sigma-Aldrich | C8667 | |
Plavix | Sanofi | Clopidogrel | |
Coronary stent (bare metal, drug eluting, biodegradable) | Stent should be selected according to the study plan. Stent length 18-25mm and diameter 2.5-3.5mm | ||
Domitor | Orion | medetomide | |
Dragonfly Optis OCT catheter | Abbott | C408646 | Use catheter compatible with available imaging system |
Enoxaparine | Sanofi | Clexane | |
Ethanol | Sigma-Aldrich | 32221-M | |
Fentanyl | Biocodex | ||
Guide wire, coronary | Cordis | 507114 | |
Guide wire, J tip | Cordis | 502717 | |
Guiding catheter AR1 | Cordis | 670-110-00 | |
Guiding catheter AR2 | Cordis | 670-112-00 | |
Guiding catheter straight | Cordis | 55626090 | |
Indeflator | Medtronic | AC3200 | Indeflator for stent balloon inflation and deflation |
Introducer sheath 5F | Cordis | 504605P | |
Introducer Sheath 6F | Cordis | 504606X | |
Ketalar | Pfizer | Ketamine | |
Microsurgical set | Mediq | FBL-SET | S&T , basic lab set for example |
Paraformaldehyde | VWR | VWRRC28794.295 | Prepare 1% and 4% solutions |
Propofol | B. Braun | ||
Suture | OneMed | JOH8685H | 5-0, nonresorbable |
Suture | OneMed | JOHFH1642H | 4-0 resorbable |
Technovit 9100 | Kulzer | ||
Ultrasound with linear transducer | Philips | ||
Vacuum chamber | SP Bel-Art | F42043-0000 | |
X-Ray contrast agent | Iomeron | ||
Xylene | Sigma-Aldrich | 534056 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved